4.5 Article

Heartbeat: sudden cardiac death risk in patients with hypertrophic cardiomyopathy

Related references

Note: Only part of the references are listed.
Editorial Material Cardiac & Cardiovascular Systems

Low-normal systolic function and hypertrophic cardiomyopathy

Pawel Rubis

HEART (2023)

Review Cardiac & Cardiovascular Systems

Anatomy of the mitral valve relative to controversies concerning the so-called annular disjunction

Robert H. Anderson et al.

Summary: It is widely accepted that the mitral valve functions through a complex combination of different components. However, controversies still exist in the understanding and description of these components. It is important to accurately describe the valvar complex using appropriate terms and to utilize three-dimensional techniques for clinical imaging.

HEART (2023)

Article Cardiac & Cardiovascular Systems

Percutaneous management of acute ischaemic stroke

Helen Routledge et al.

HEART (2023)

Article Cardiac & Cardiovascular Systems

Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction

You-Jung Choi et al.

Summary: The study aimed to investigate the association between low-normal left ventricular ejection fraction (LVEF) and adverse outcomes in hypertrophic cardiomyopathy (HCM), as well as evaluate the predictive power of LVEF in the conventional HCM sudden cardiac death (SCD)-risk model. The results showed that low-normal LVEF was an independent predictor of heart failure hospitalization and cardiovascular death in patients with HCM.

HEART (2023)

Editorial Material Cardiac & Cardiovascular Systems

Understanding the anatomy of the mitral valve: attitudinal is unnecessary

Rebecca T. Hahn

HEART (2023)

Article Cardiac & Cardiovascular Systems

Impact of cardiovascular health and genetic risk on coronary artery disease in Chinese adults

Qingmei Cui et al.

Summary: This study aims to examine whether adherence to ideal cardiovascular health (CVH) can mitigate the genetic risk of coronary artery disease (CAD) in non-European populations. The results showed that individuals with a favourable CVH profile demonstrated similar relative effects across Polygenic Risk Score (PRS) categories, reducing the CAD relative risk by a similar magnitude. Individuals with high PRS achieved the greatest benefit from favourable CVH, mitigating the risk to the average level of the population. Attaining favourable CVH should be encouraged for all individuals, especially those with high genetic susceptibility.

HEART (2023)

Editorial Material Cardiac & Cardiovascular Systems

Polygenic risk, lifestyle and the lifetime risk of coronary artery disease

Paul S. de Vries

HEART (2023)